Manuscripts
Showing 1591 manuscripts.
Association of recent HIV infection and in-utero HIV-1 transmission.
Citation
Association of recent HIV infection and in-utero HIV-1 transmission. AIDS. 2011 Jul 02; 25(11):1357-64. PMID: 21572305; PMCID: PMC3263827.Year
2011
Journal
AIDS
Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
Citation
Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings. Journal of Clinical Microbiology. 2011 Dec 01; 49(12). PMID: 21956987; PMCID: PMC3232965.Year
2011
Journal
Journal of Clinical Microbiology
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial
Citation
Charles Flexner, M.D., Camlin Tierney, Ph.D., Robert Gross, M.D., M.S.C.E., Adriana Andrade, M.D., M.P.H., Christina M. Lalama, M.S., Susan H. Eshleman, M.D., PH.D., Judith A. Aberg, M.D., Ian M. Sanne, M.D., FCP (medicine), DTM&H, Teresa Parsons, Ph.D., Angela D.M. Kashuba, Pharm.D., Susan L Rosenkranz, Ph.D., Anne Kmack, B.S., Elaine Ferguson, R.Ph., M.S., Marjorie Dehlinger, D.N.Sc., Donna Mildvan, M.D. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical Infectious Diseases. 2010 Apr 01; 50(7):1041-52. PMID: 20192725; PMCID: PMC2833234.Year
2010
Journal
Clinical Infectious Diseases
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV
Citation
Timothy Schacker, M.D., Ronald J. Bosch, Ph.D., Kara Bennett, M.S., Richard B. Pollard, M.D., Gregory K. Robbins, M.D., M.P.H., Ann C. Collier, M.D., Roy (Trip) Gulick, M.D., M.P.H., John Spritzler, Sc.D., Donna Mildvan, M.D. Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. Journal of Acquired Immune Deficiency Syndromes. 2010 May 01; 54(1):59-62. PMID: 20182359; PMCID: PMC2955357.Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs
Citation
Mina John, David Heckerman, Larry Park, Ian James, Jonathan Carlson, Abha Chopra, Silvana Gaudieri, David Nolan, Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Simon Mallal. Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. Journal of Immunology. 2010 Apr 15; 184(8):4368-77. PMID: 20231689; PMCID: PMC3011274.Year
2010
Journal
Journal of Immunology
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
Citation
Rajesh Gandhi, M.D., Ronald J. Bosch, Ph.D., Evgenia Aga, M.Sc., Mary Albrecht, M.D., Lisa M. Demeter, M.D., Carrie Dykes, Ph.D., Barbara Bastow, R.N., B.S.N., Michael F. Para, M.D., J. P. Lai, Robert F. Siliciano, M.D., Ph.D., Janet M. Siliciano, Ph.D., Joseph J. Eron, Jr., M.D. No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy. Journal of Infectious Diseases. 2010 Jan 15; 201(2):293-6. PMID: 20001856; PMCID: PMC2887684.Year
2010
Journal
Journal of Infectious Diseases
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate
Citation
Athe Tsibris, M.D. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. Journal of Acquired Immune Deficiency Syndromes. 2010 Dec 01; 55(4):420-7. PMID: 20856130; PMCID: PMC3070184.Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens
Citation
Kenneth E. Sherman, M.D., Ph.D., Susan D. Rouster, B.S., S. Stanford, Jason T. Blackard, Ph.D., Norah Shire, M.P.H., Margaret James Koziel, M.D., Marion G. Peters, M.D., Raymond T. Chung, M.D. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. Journal of Infectious Diseases. 2010 Mar 01; 201(5):712-9. PMID: 20105080; PMCID: PMC2827649.Year
2010
Journal
Journal of Infectious Diseases
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328)
Citation
Ronald J. Bosch, Ph.D., Richard B. Pollard, M.D., Alan Landay, Ph.D., Evgenia Aga, M.Sc., Lawrence Fox, M.D., Ph.D., Ronald T. Mitsuyasu, M.D. Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328). AIDS Research & Therapy (online journal). 2010 Aug 05; 7(30):30. PMID: 20687947; PMCID: PMC2924251.Year
2010
Journal
AIDS Research & Therapy (online journal)
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.
Citation
Kevin R. Robertson, Ph.D. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010 Apr 20; 74(16):1260-6. PMID: 20237308; PMCID: PMC2860482.Year
2010
Journal
Neurology